Cite
HARVARD Citation
Friedlander, P. et al. (2018). A whole-blood RNA transcript-based gene signature is associated with the development of CTLA-4 blockade-related diarrhea in patients with advanced melanoma treated with the checkpoint inhibitor tremelimumab. Journal for immunotherapy of cancer. 6 (1), p. . [Online].